glp 1 agonists vs sglt2 inhibitors and combination + GLP-1 RAs may lower cardiorenal risk in T2D SGLT2 inhibitors and GLP-1 receptor

Impact of aortic stiffness on survival in end-stage renal disease

The role of atherectomy in the treatment of lower extremity peripheral artery disease

JBMR Plus

In SURMOUNT-1, a study in 2,539 adults with obesity, or excess weight and weight-related medical problems not including diabetes, people taking Zepbound as an adjunct to diet and exercise experienced substantial weight loss compared with placebo at 72 weeks

Reviewers will look for a well-rounded team to execute the proposed scope of work

Performance Essentials uses the trademarked brand GBBGO because of the proven consistency and quality with this material